Expert insights. Personalized for you.
and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc’s software into Lilly’s connected insulin solutions, currently in development. Under the terms of the agreement, Lilly and Welldoc will collaborate to create a new version of the BlueStar ® insulin management solution that integrates insulin dosing data for several Lilly insulins. Welldoc, Inc., MORE
Generic drugmaker Mylan has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi’s once-daily insulin Lantus. MORE
Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. The U.S. MORE
A new type of self-injecting capsule could deliver medications at comparable levels to those given via injection, according to a preclinical study. Bio Developments MORE
approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. “The expansion of the Lyumjev label to include use in an insulin pump provides a new and important choice for people with diabetes. MORE
Adocia’s Partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China Adocia’s Partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial … Continue reading → GlobeNewswire MORE
Billion Global Rapid Acting Insulin Market (2021 to 2027) – Industry Analysis Report and Forecasts – ResearchAndMarkets.com $11.4 Billion Global Rapid Acting Insulin Market (2021 to 2027) – Industry Analysis Report and Forecasts – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Rapid … Continue reading → Business Wire MORE
rBIO launched last week with technology that can reduce the cost of insulin by 30 percent, making U.S. manufacturing cost-effective for insulin and several other drugs MORE
No specific financial details were disclosed other than to say the $1 billion figure was linked to various development and commercial milestones MORE
New Soliqua ® * data shows improved blood sugar control without weight gain versus premixed insulin. While premix ed is used by around 4 0% of people taking insulin globally to manage their type 2 diabetes today, recent real-world evidence suggests only 18.2% premixed insulin). MORE
Insulin costs have been a controversial topic in pharma for years, with the leading manufacturers facing routine scrutiny for their pricing… The post In collab with Novo Nordisk, Walmart says it will ‘revolutionize’ insulin access with deep discounts appeared first on Journal for Clinical Studies. MORE
Adocia’s partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China Adocia’s partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial … Continue reading → GlobeNewswire MORE
UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced properties. The initial therapeutic focus is diabetes, with three insulin-based products in development. MORE
Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections. MORE
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eli Lilly’s $1B buyout bet for Protomer sees it grab the ‘next frontier’ in smart insulin tech.Eli Lilly’s $1B buyout bet for Protomer sees it grab the … Continue reading → #news MORE
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Controlling insulin production with a smartwatch.Many modern fitness trackers and smartwatches feature integrated LEDs. The green light emitted, whether continuous or pulsed, penetrates the skin and can … Continue reading → #news MORE
Pancreatic beta cells produce, store and secrete insulin upon elevated blood glucose levels. However, the highly regulated process of insulin secretion, especially its molecular features and the stimuli behind this process have not yet been fully understood. MORE
ACTON, Mass.–(BUSINESS MORE
2020 Report on Insulin Resistance R&D Pipeline Analysis – Small Insulin Resistance Companies Look for Licensing and Collaboration Partners – ResearchAndMarkets.com 2020 Report on Insulin Resistance R&D Pipeline Analysis – Small Insulin Resistance Companies Look for Licensing and Collaboration Partners … Continue reading → Business Wire MORE
Investigational therapy also led to superior body weight reductions in adults with type 2 diabetes MORE
Eli Lilly's SURPASS-4 trial program shows tirzepatide, significantly reduced blood glucose levels and body weight better than insulin glargine in adult patients with type 2 diabetes MORE
retail pharmacies Monthly prescriptions for all Lilly insulins — including Insulin Lispro Injection — remain available for $35 through the Lilly Insulin Value Program and the Medicare Part D Senior Savings Model. MORE
Fractyl Announces FDA Breakthrough Device Designation for Revita® DMR in Insulin-Treated Type 2 Diabetes Fractyl Announces FDA Breakthrough Device Designation for Revita® DMR in Insulin-Treated Type 2 Diabetes – REVITA-T2Di study is underway to evaluate the effectiveness of Revita DMR … Continue reading → Business Wire MORE
Arecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetes Arecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetes … Continue reading → GlobeNewswire MORE
Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright. . MORE
The injection experience is an often-overlooked aspect in insulin administration. For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. Insulin Needle Design and Technology. MORE
The editorial team also discussed Medtronic’s expanded recalls of the remote controllers for certain models of its MiniMed insulin pumps over cybersecurity concerns, as well as its 600 series insulin pumps due to a faulty retainer ring. MORE
Amalgam Rx™ Receives CE Mark for Basal Insulin Titration Amalgam Rx™ Receives CE Mark for Basal Insulin Titration Insulin Titration App Meets Requirements for European Launch WILMINGTON, Del.–(BUSINESS –(BUSINESS WIRE)–#cemarking–Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences … Continue reading → Business Wire MORE
Liquid Dosage Pharma aseptic Cartridge Closing Filling Insulin Processing MORE
Findings point to possible treatment for smell loss Credit: Monell Chemical Senses Center, eNeuro PHILADELPHIA (May 17, 2021) – Researchers have known for some time that insulin plays a vital role in regeneration and growth in some types of neurons that relay environmental sensory information to our brains, such as sight. MORE
publishers New Rochelle, NY, January 26, 2021–Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. Credit: Mary Ann Liebert, Inc., MORE
China Recombinant Lispro Insulin Market Report 2021-2025 Featuring Lilly & Gan & Lee Pharmaceuticals – ResearchAndMarkets.com China Recombinant Lispro Insulin Market Report 2021-2025 Featuring Lilly & Gan & Lee Pharmaceuticals – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Recombinant Lispro … Continue reading → Business Wire MORE
Global Insulin Pumps Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com Global Insulin Pumps Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Insulin Pumps … Continue reading → Business Wire MORE
Global Oral Insulin Market Report 2021-2025: Size & Forecast with Impact Analysis of COVID-19 on Healthcare Sector, Diabetic Patients, & Oral Insulin – ResearchAndMarkets.com Global Oral Insulin Market Report 2021-2025: Size & Forecast with Impact Analysis of COVID-19 on Healthcare … Continue reading → Business Wire MORE
Study finds Omnipod® 5 simplifies diabetes management in type 1 diabetes WASHINGTON–People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation’s Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy. MORE
This cohort study compares the associations of long-acting insulin analogs and NPH insulin with the risk of severe hypoglycemia in older patients with type 2 diabetes MORE
Credit: ETH Zurich Many modern fitness trackers and smartwatches feature integrated LEDs. The green light emitted, whether continuous or pulsed, penetrates the skin and can be used to measure the wearer’s heart rate during physical activity or while at rest. MORE
Medtronic has expanded a Class I recall of remote controllers used with the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps over potential cybersecurity risks. MORE
DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025” report has been added to ResearchAndMarkets.com’s offering. “Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025” Report Highlights: Diabetes Drug Market Opportunity: > … Continue reading → Business Wire MORE
Worldwide Rapid Acting Insulin Industry to 2027 – Sedentary and Unhealthy Lifestyles are Driving Growth – ResearchAndMarkets.com Worldwide Rapid Acting Insulin Industry to 2027 – Sedentary and Unhealthy Lifestyles are Driving Growth – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Rapid Acting Insulin Market … Continue reading → Business Wire MORE
Insights on the Human Insulin Global Market to 2026 – by Product Type, Distribution Type, Disease Type and Region – ResearchAndMarkets.com Insights on the Human Insulin Global Market to 2026 – by Product Type, Distribution Type, Disease Type and Region … Continue reading → Business Wire MORE
Rival Novo Nordisk has jumped ahead in developing an injectable drug that responds to changes in blood sugar. An acquisition of Protomer Therapeutics could help Lilly close the gap MORE
In Episode 1 of the Xtalks Life Science Podcast, Sarah discusses a new condition called “Mask-Associated Dry Eye” and Ayesha talks about Droplet Micron, an innovative insulin needle. And hear from Anu Rajora, director of medical marketing at HTL-STREFA, the company behind the innovative Droplet Micron insulin needle, who explains why technology needs to make it easier for patients to adhere to medication schedules. MORE
Insulin Related Topics XTalks
OCTOBER 8, 2021
Medtronic has expanded a Class I recall of remote controllers used with the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps over potential cybersecurity risks.
Scienmag
SEPTEMBER 29, 2021
Pancreatic beta cells produce, store and secrete insulin upon elevated blood glucose levels. However, the highly regulated process of insulin secretion, especially its molecular features and the stimuli behind this process have not yet been fully understood.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JULY 14, 2021
Rival Novo Nordisk has jumped ahead in developing an injectable drug that responds to changes in blood sugar. An acquisition of Protomer Therapeutics could help Lilly close the gap
Pharma Phorum
JULY 14, 2021
Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright. .
XTalks
OCTOBER 13, 2021
The editorial team also discussed Medtronic’s expanded recalls of the remote controllers for certain models of its MiniMed insulin pumps over cybersecurity concerns, as well as its 600 series insulin pumps due to a faulty retainer ring.
Scienmag
MAY 17, 2021
Findings point to possible treatment for smell loss Credit: Monell Chemical Senses Center, eNeuro PHILADELPHIA (May 17, 2021) – Researchers have known for some time that insulin plays a vital role in regeneration and growth in some types of neurons that relay environmental sensory information to our brains, such as sight.
The Pharma Data
AUGUST 17, 2021
approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. “The expansion of the Lyumjev label to include use in an insulin pump provides a new and important choice for people with diabetes.
Pharma Phorum
JULY 29, 2021
Generic drugmaker Mylan has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi’s once-daily insulin Lantus.
The Pharma Data
SEPTEMBER 30, 2021
retail pharmacies Monthly prescriptions for all Lilly insulins — including Insulin Lispro Injection — remain available for $35 through the Lilly Insulin Value Program and the Medicare Part D Senior Savings Model.
Scienmag
MARCH 20, 2021
Study finds Omnipod® 5 simplifies diabetes management in type 1 diabetes WASHINGTON–People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation’s Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy.
Syntegon Technology Pharma Blog
SEPTEMBER 28, 2021
Liquid Dosage Pharma aseptic Cartridge Closing Filling Insulin Processing
BioSpace
DECEMBER 28, 2020
rBIO launched last week with technology that can reduce the cost of insulin by 30 percent, making U.S. manufacturing cost-effective for insulin and several other drugs
XTalks
MARCH 26, 2021
In Episode 1 of the Xtalks Life Science Podcast, Sarah discusses a new condition called “Mask-Associated Dry Eye” and Ayesha talks about Droplet Micron, an innovative insulin needle. And hear from Anu Rajora, director of medical marketing at HTL-STREFA, the company behind the innovative Droplet Micron insulin needle, who explains why technology needs to make it easier for patients to adhere to medication schedules.
Scienmag
JANUARY 26, 2021
publishers New Rochelle, NY, January 26, 2021–Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. Credit: Mary Ann Liebert, Inc.,
XTalks
SEPTEMBER 23, 2020
Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections.
Pharma Phorum
MAY 17, 2021
UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced properties. The initial therapeutic focus is diabetes, with three insulin-based products in development.
BioTech 365
JUNE 16, 2021
Amalgam Rx™ Receives CE Mark for Basal Insulin Titration Amalgam Rx™ Receives CE Mark for Basal Insulin Titration Insulin Titration App Meets Requirements for European Launch WILMINGTON, Del.–(BUSINESS –(BUSINESS WIRE)–#cemarking–Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences … Continue reading → Business Wire
BioTech 365
APRIL 16, 2021
2020 Report on Insulin Resistance R&D Pipeline Analysis – Small Insulin Resistance Companies Look for Licensing and Collaboration Partners – ResearchAndMarkets.com 2020 Report on Insulin Resistance R&D Pipeline Analysis – Small Insulin Resistance Companies Look for Licensing and Collaboration Partners … Continue reading → Business Wire
BioSpace
MAY 19, 2021
Eli Lilly's SURPASS-4 trial program shows tirzepatide, significantly reduced blood glucose levels and body weight better than insulin glargine in adult patients with type 2 diabetes
JAMA Internal Medicine
FEBRUARY 28, 2021
This cohort study compares the associations of long-acting insulin analogs and NPH insulin with the risk of severe hypoglycemia in older patients with type 2 diabetes
BioTech 365
SEPTEMBER 21, 2020
ACTON, Mass.–(BUSINESS
The Pharma Data
JULY 29, 2021
Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. The U.S.
BioTech 365
OCTOBER 14, 2021
Adocia’s Partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China Adocia’s Partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial … Continue reading → GlobeNewswire
BioTech 365
OCTOBER 14, 2021
Adocia’s partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China Adocia’s partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial … Continue reading → GlobeNewswire
XTalks
FEBRUARY 24, 2021
The injection experience is an often-overlooked aspect in insulin administration. For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. Insulin Needle Design and Technology.
BioSpace
JULY 13, 2021
No specific financial details were disclosed other than to say the $1 billion figure was linked to various development and commercial milestones
BioTech 365
APRIL 27, 2021
Fractyl Announces FDA Breakthrough Device Designation for Revita® DMR in Insulin-Treated Type 2 Diabetes Fractyl Announces FDA Breakthrough Device Designation for Revita® DMR in Insulin-Treated Type 2 Diabetes – REVITA-T2Di study is underway to evaluate the effectiveness of Revita DMR … Continue reading → Business Wire
The Pharma Data
JUNE 29, 2021
New Soliqua ® * data shows improved blood sugar control without weight gain versus premixed insulin. While premix ed is used by around 4 0% of people taking insulin globally to manage their type 2 diabetes today, recent real-world evidence suggests only 18.2% premixed insulin).
BioTech 365
JUNE 7, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Controlling insulin production with a smartwatch.Many modern fitness trackers and smartwatches feature integrated LEDs. The green light emitted, whether continuous or pulsed, penetrates the skin and can … Continue reading → #news
BioTech 365
APRIL 16, 2021
Global Oral Insulin Market Report 2021-2025: Size & Forecast with Impact Analysis of COVID-19 on Healthcare Sector, Diabetic Patients, & Oral Insulin – ResearchAndMarkets.com Global Oral Insulin Market Report 2021-2025: Size & Forecast with Impact Analysis of COVID-19 on Healthcare … Continue reading → Business Wire
BioTech 365
MAY 31, 2021
Worldwide Rapid Acting Insulin Industry to 2027 – Sedentary and Unhealthy Lifestyles are Driving Growth – ResearchAndMarkets.com Worldwide Rapid Acting Insulin Industry to 2027 – Sedentary and Unhealthy Lifestyles are Driving Growth – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Rapid Acting Insulin Market … Continue reading → Business Wire
BioTech 365
MAY 26, 2021
Global Insulin Pumps Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com Global Insulin Pumps Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Insulin Pumps … Continue reading → Business Wire
BioTech 365
JULY 22, 2021
Billion Global Rapid Acting Insulin Market (2021 to 2027) – Industry Analysis Report and Forecasts – ResearchAndMarkets.com $11.4 Billion Global Rapid Acting Insulin Market (2021 to 2027) – Industry Analysis Report and Forecasts – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Rapid … Continue reading → Business Wire
Journal for Clinical Studies
JUNE 30, 2021
Insulin costs have been a controversial topic in pharma for years, with the leading manufacturers facing routine scrutiny for their pricing… The post In collab with Novo Nordisk, Walmart says it will ‘revolutionize’ insulin access with deep discounts appeared first on Journal for Clinical Studies.
Pharma Times
MAY 21, 2021
Investigational therapy also led to superior body weight reductions in adults with type 2 diabetes
BioTech 365
SEPTEMBER 20, 2021
Arecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetes Arecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetes … Continue reading → GlobeNewswire
BioPharma Reporter
AUGUST 30, 2021
A new type of self-injecting capsule could deliver medications at comparable levels to those given via injection, according to a preclinical study. Bio Developments
BioTech 365
APRIL 21, 2021
China Recombinant Lispro Insulin Market Report 2021-2025 Featuring Lilly & Gan & Lee Pharmaceuticals – ResearchAndMarkets.com China Recombinant Lispro Insulin Market Report 2021-2025 Featuring Lilly & Gan & Lee Pharmaceuticals – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Recombinant Lispro … Continue reading → Business Wire
BioTech 365
JULY 13, 2021
Insights on the Human Insulin Global Market to 2026 – by Product Type, Distribution Type, Disease Type and Region – ResearchAndMarkets.com Insights on the Human Insulin Global Market to 2026 – by Product Type, Distribution Type, Disease Type and Region … Continue reading → Business Wire
The Pharma Data
FEBRUARY 25, 2021
and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc’s software into Lilly’s connected insulin solutions, currently in development. Under the terms of the agreement, Lilly and Welldoc will collaborate to create a new version of the BlueStar ® insulin management solution that integrates insulin dosing data for several Lilly insulins. Welldoc, Inc.,
BioTech 365
JULY 14, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eli Lilly’s $1B buyout bet for Protomer sees it grab the ‘next frontier’ in smart insulin tech.Eli Lilly’s $1B buyout bet for Protomer sees it grab the … Continue reading → #news
BioTech 365
SEPTEMBER 8, 2020
DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025” report has been added to ResearchAndMarkets.com’s offering. “Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025” Report Highlights: Diabetes Drug Market Opportunity: > … Continue reading → Business Wire
40 
Let's personalize your content